About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Uterine Leiomyosarcoma: a Management Dilemma

paroxetine effet

paroxetine
Sunita Gupta, Geetika, Rani Bansal1, Himanshu Chauhan2

From the Department of Obstetrics and Gynecology; Department of Pathology1; Department of Anaesthesia and Critical care2; Subharti Institute of Medical Sciences, Meerut, India.
Corresponding Author:
Dr. Sunita Gupta

Email: drsunitachauhan@gmail.com
Received: 18-JAN-2013 Accepted: 20-MAR-2013 Published Online: 10-MAY-2013
DOI: http://dx.doi.org/10.17659/01.2013.0033
Abstract
Uterine leiomyosarcoma (ULMS) are rare and aggressive smooth muscle tumours accounting for approximately 1% of patients with uterine cancer. ULMS are neoplasm’s of high metastatic potential. Diagnosis of leiomyosarcoma is often made after hysterectomy as symptoms and signs are nonspecific and imaging methods fail to differentiate it from benign conditions. Trans (abdominal) hysterectomy was performed in a 38 year old female with a provisional diagnosis of fibroid uterus. Histopathology showed leiomyosarcoma stage 3A. Patient refused for chemotherapy and developed recurrence in 6 months and succumbed after 3 months of recurrence. ULMS continue to provide a major challenge for treatment of the primary presentation and for relapses.
Keywords : Uterine Neoplasms, Leiomyosarcoma, Adjuvant Chemotherapy, Smooth Muscle Tumor, Leiomyoma.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share